Chronic natural killer cell lymphocytosis is associated with elevated cytotoxic activity of natural killer cells

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 2, 2005, Pages 85-89

  Wex, Heike ^a,c   Aumann, Volker ^a   Häusler, Martin ^b   Vorwerk, Peter ^a   Mittler, Uwe ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Case report; Child; Cytotoxic activity; IgE; Natural killer cell lymphocytosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIGEN; ANTIHISTAMINIC AGENT; CD11B ANTIGEN; CD16 ANTIGEN; CD161 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; DICLOFENAC; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY; DOT HYBRIDIZATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTOSIS; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADOLESCENT; CHRONIC DISEASE; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; KILLER CELLS, NATURAL; LYMPHOCYTOSIS;

EID: 13944280330     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000152571.06437.3f     Document Type: Article

References (22)

1. Comans-Bitter WM, de Groot R, van den BR, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388-393.
2. Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev. 1998;165:75-86.
3. Moretta A, Vitale M, Sivori S, et al. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med. 1994;180:545-555.
4. Mori KL, Egashira M, Oshimi K. Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. Br J Haematol. 2001;115:225-228.
5. Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol. 1990;75:49-59.
6. Tefferi A. Chronic natural killer cell lymphocytosis. Leuk Lymphoma. 1996;20:245-248.
7. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1-14.
8. Sivakumaran M, Richards S. Immunological abnormalities of chronic large granular lymphocytosis. Clin Lab Haematol. 1997;19:57-60.
9. Vorwerk P, Wex H, Hohmann B, et al. Expression of components of the IGF signalling system in childhood acute lymphoblastic leukaemia. Mol Pathol. 2002;55:40-45.
10. Piriou L, Chilmonczyk S, Genetet N, et al. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry. 2000;41:289-297.
11. Morice WG, Leibson PJ, Tefferi A. Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis. Leuk Lymphoma. 2001;41:277-284.
12. Nizet Y, Chentoufi AA, Havaux X, et al. Apoptosis of human naive NK cells mediated by a rat IgG2b anti CD2 mAb through a fractricidal ADCC reaction. Immunol Lett. 1999;68:229-235.
13. Sivakumaran M, Richards SJ, Scott CS. Clinical and laboratory characteristics of chronic natural killer cell lymphocytosis. Blood. 1996;87:1659-1660.
14. Scott CS, Richards SJ, Sivakumaran M, et al. Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: the Yorkshire Leukaemia Group Study. Br J Haematol. 1993;83:505-515.
15. Zambello R, Loughran TP Jr, Trentin L, et al. Spontaneous resolution of p58/EB6 antigen restricted NK-type lymphoproliferative disease of granular lymphocytes: role of Epstein-Barr virus infection. Br J Haematol. 1997;99:215-221.
16. Ishiyama T, Koike M, Watanabe K, et al. Natural killer (NK) lymphocytosis induced by Epstein-Barr virus (EBV) reactivation in monoclonal gammopathy of undetermined significance (MGUS). Clin Exp Immunol. 1996;105:46-51.
17. Hudnall SD, Patel J, Schwab H, et al. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis. Cytometry. 2003;55B:22-28.
18. Satoh M, Oyama N, Akiba H, et al. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implications of Epstein-Barr virus reactivation. Eur J Dermatol. 2002;12:381-384.
19. Saxon A, Ke Z, Bahati L, et al. Soluble CD23 containing B-cell supernatant induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. J Allergy Clin Immunol. 1990;86:333-344.
20. Takizawa F, Adamczewski M, Kinet JP. Identification of the low-affinity receptor for immunoglobulin E on mouse mast cells and macrophages as Fc gamma RII and Fc gamma RIII. J Exp Med. 1992;176:469-475.
21. Arase N, Arase H, Hirano S, et al. IgE-mediated activation of NK cells through Fc gamma RIII. J Immunol. 2003;170:3054-3058.
22. Kusaka Y, Sato K, Zhang Q, et al. Association of natural killer cell activity with serum IgE. Int Arch Allergy Immunol. 1997;112:331-335.